-
Je něco špatně v tomto záznamu ?
Clinical Outcome Assessments for Spasticity: Review, Critique, and Recommendations
O. Gal, M. Baude, T. Deltombe, A. Esquenazi, JM. Gracies, M. Hoskovcova, C. Rodriguez-Blazquez, R. Rosales, L. Satkunam, J. Wissel, T. Mestre, Á. Sánchez-Ferro, M. Skorvanek, MHS. Tosin, R. Jech, members of the MDS Clinical Outcome Assessments...
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, přehledy
Grantová podpora
LX22NPO5107
National Institute for Neurological Research Progamme EXCELES
PubMed
39629752
DOI
10.1002/mds.30062
Knihovny.cz E-zdroje
- MeSH
- hodnocení výsledků zdravotní péče * normy MeSH
- lidé MeSH
- svalová spasticita * patofyziologie diagnóza etiologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
BACKGROUND: Spasticity is a common feature in patients with disruptions in corticospinal pathways. However, the term is used ambiguously. Here, spasticity is defined as enhanced velocity-dependent stretch reflexes and placed within the context of deforming spastic paresis encompassing other forms of muscle overactivity. OBJECTIVE: This scoping review aims at evaluating the clinimetric quality of clinical outcome assessments (COAs) for spasticity across different pathologies and to make recommendations for their use. METHODS: A literature search was conducted to identify COAs used to assess spasticity. An international expert panel evaluated the measurement properties in the included COAs. Recommendations were based on the MDS-COA program methodology based on three criteria: if the COA was (1) applied to patients with spastic paresis, (2) used by others beyond the developers, and (3) determined to be reliable, valid, and sensitive to change in patients with spasticity. RESULTS: We identified 72 COAs of which 17 clinician-reported outcomes (ClinROs) and 6 patient-reported outcomes (PROs) were reviewed. The Tardieu Scale was the only ClinRO recommended for assessing spasticity. One ClinRO-Composite Spasticity Index-and two PROs-Spasticity 0-10 Numeric Rating Scale and 88-Item Multiple Sclerosis Spasticity Scale-were recommended with caveats. The Ashworth-derived COAs were excluded after evaluation due to their focus on muscle tone rather than spasticity, as defined in this review. CONCLUSIONS: The Tardieu Scale is recommended for assessing spasticity, and two PROs are recommended with caveats. Consistent terminology about the various types of muscle overactivity is necessary to facilitate their assessment and treatment. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
BIOTN Laboratory EA 7377 BIOTN Université Paris Est Créteil Créteil France
CIBERNED Institute of Health Carlos 3 Madrid Spain
Department of Medicine University of Alberta Edmonton Alberta Canada
Department of Neurological Sciences Rush University Medical Center Chicago Illinois USA
Department of Neurology General University Hospital Prague Prague Czech Republic
Department of Neurology P J Šafárik University Košice Slovakia
Department of Neurology University Hospital of L Pasteur Košice Slovakia
Department of Physical Medicine and Rehabilitation CHU UCL Namur Site Godinne Yvoir Belgium
Jefferson Moss Magee Rehabilitation Philadelphia Pennsylvania USA
National Centre of Epidemiology Institute of Health Carlos 3 Madrid Spain
Neurology and Psychosomatic at Wittenbergplatz Berlin Germany
Service de Neurorééducation Université de Corse Centre Hospitalier de Bastia Bastia France
University of Ottawa Brain and Mind Institute Ottawa Ontario Canada
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25010452
- 003
- CZ-PrNML
- 005
- 20250429134736.0
- 007
- ta
- 008
- 250415s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/mds.30062 $2 doi
- 035 __
- $a (PubMed)39629752
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Gal, Ota $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Neurology, General University Hospital in Prague, Prague, Czech Republic $1 https://orcid.org/0000000286142776 $7 xx0172029
- 245 10
- $a Clinical Outcome Assessments for Spasticity: Review, Critique, and Recommendations / $c O. Gal, M. Baude, T. Deltombe, A. Esquenazi, JM. Gracies, M. Hoskovcova, C. Rodriguez-Blazquez, R. Rosales, L. Satkunam, J. Wissel, T. Mestre, Á. Sánchez-Ferro, M. Skorvanek, MHS. Tosin, R. Jech, members of the MDS Clinical Outcome Assessments Scientific Evaluation Committee and MDS Spasticity Study group
- 520 9_
- $a BACKGROUND: Spasticity is a common feature in patients with disruptions in corticospinal pathways. However, the term is used ambiguously. Here, spasticity is defined as enhanced velocity-dependent stretch reflexes and placed within the context of deforming spastic paresis encompassing other forms of muscle overactivity. OBJECTIVE: This scoping review aims at evaluating the clinimetric quality of clinical outcome assessments (COAs) for spasticity across different pathologies and to make recommendations for their use. METHODS: A literature search was conducted to identify COAs used to assess spasticity. An international expert panel evaluated the measurement properties in the included COAs. Recommendations were based on the MDS-COA program methodology based on three criteria: if the COA was (1) applied to patients with spastic paresis, (2) used by others beyond the developers, and (3) determined to be reliable, valid, and sensitive to change in patients with spasticity. RESULTS: We identified 72 COAs of which 17 clinician-reported outcomes (ClinROs) and 6 patient-reported outcomes (PROs) were reviewed. The Tardieu Scale was the only ClinRO recommended for assessing spasticity. One ClinRO-Composite Spasticity Index-and two PROs-Spasticity 0-10 Numeric Rating Scale and 88-Item Multiple Sclerosis Spasticity Scale-were recommended with caveats. The Ashworth-derived COAs were excluded after evaluation due to their focus on muscle tone rather than spasticity, as defined in this review. CONCLUSIONS: The Tardieu Scale is recommended for assessing spasticity, and two PROs are recommended with caveats. Consistent terminology about the various types of muscle overactivity is necessary to facilitate their assessment and treatment. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a svalová spasticita $x patofyziologie $x diagnóza $x etiologie $7 D009128
- 650 12
- $a hodnocení výsledků zdravotní péče $x normy $7 D017063
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Baude, Marjolaine $u Service de Rééducation Neurolocomotrice, Hôpitaux Universitaires Henri-Mondor, Assistance publique-Hôpitaux de Paris, Créteil, France $u BIOTN Laboratory, EA 7377 BIOTN, Université Paris-Est Créteil, Créteil, France
- 700 1_
- $a Deltombe, Thierry $u Department of Physical Medicine & Rehabilitation, CHU UCL Namur Site Godinne, Yvoir, Belgium
- 700 1_
- $a Esquenazi, Alberto $u Jefferson Moss-Magee Rehabilitation, Philadelphia, Pennsylvania, USA
- 700 1_
- $a Gracies, Jean-Michel $u BIOTN Laboratory, EA 7377 BIOTN, Université Paris-Est Créteil, Créteil, France $u Service de Neurorééducation, Université de Corse, Centre Hospitalier de Bastia, Bastia, France
- 700 1_
- $a Hoskovcova, Martina $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Neurology, General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Rodriguez-Blazquez, Carmen $u National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain $u CIBERNED, Institute of Health Carlos III, Madrid, Spain
- 700 1_
- $a Rosales, Raymond $u Faculty of Medicine and Surgery-Research Center for Health Sciences and Dept. Of Neuroscience, University of Santo Tomas (and Hospital), Manila, Philippines
- 700 1_
- $a Satkunam, Lalith $u Division of Physical Medicine & Rehabilitation, Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada $u Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
- 700 1_
- $a Wissel, Jörg $u Neurology and Psychosomatic at Wittenbergplatz, Berlin, Germany $u University of Potsdam, Potsdam, Germany $1 https://orcid.org/0000000162383578
- 700 1_
- $a Mestre, Tiago $u Parkinson's Disease and Movement Disorders Clinic, Division of Neurology, Department of Medicine, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada $u University of Ottawa Brain and Mind Institute, Ottawa, Ontario, Canada
- 700 1_
- $a Sánchez-Ferro, Álvaro $u CIBERNED, Institute of Health Carlos III, Madrid, Spain $u Movement Disorders Unit, Neurology Department, Hospital Universitario Instituto de Investigación Sanitaria (imas12) 12 de Octubre, Madrid, Spain
- 700 1_
- $a Skorvanek, Matej $u Department of Neurology, P. J. Šafárik University, Košice, Slovakia $u Department of Neurology, University Hospital of L. Pasteur, Košice, Slovakia $1 https://orcid.org/0000000154978715 $7 xx0225963
- 700 1_
- $a Tosin, Michelle Hyczy de Siqueira $u Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA $1 https://orcid.org/0000000173091407
- 700 1_
- $a Jech, Robert $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Neurology, General University Hospital in Prague, Prague, Czech Republic $1 https://orcid.org/0000000297328947 $7 xx0082225
- 710 2_
- $a members of the MDS Clinical Outcome Assessments Scientific Evaluation Committee and MDS Spasticity Study group
- 773 0_
- $w MED00003420 $t Movement disorders $x 1531-8257 $g Roč. 40, č. 1 (2025), s. 22-43
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39629752 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429134732 $b ABA008
- 999 __
- $a ok $b bmc $g 2311669 $s 1247533
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 40 $c 1 $d 22-43 $e 20241204 $i 1531-8257 $m Movement disorders $n Mov Disord $x MED00003420
- GRA __
- $a LX22NPO5107 $p National Institute for Neurological Research Progamme EXCELES
- LZP __
- $a Pubmed-20250415
